Click on the image to zoom

10 Years!

In the vibrant tech landscape of Tallinn, Estonia, our company emerged in 2014 with a vision to revolutionize software development. Fast forward to the present day, and Recursive Software Development is celebrating its 10th anniversary, marking a decade of resilience, growth, and groundbreaking achievements. Here's a brief recap of our remarkable journey, highlighting its milestones over challenges and our most recent pivotal role in the world of GxP and Pharma.

A Decade of Resilience and Growth

Since its inception, Recursive Software Development has experienced consistent growth, boasting an average annual growth rate of 57%. This achievement is particularly noteworthy considering the numerous challenges the company faced, including a global pandemic, a cyber attack, and countless IT emergencies. Despite these obstacles, Recursive not only weathered the storms but emerged stronger each time, a testament to our resilience and adaptability.

Navigating the Global Pandemic

The COVID-19 pandemic presented unprecedented challenges for businesses worldwide, forcing them to adapt quickly to remote work and changing market dynamics. Recursive Software Development not only adapted to the new normal but also leveraged the situation as an opportunity for innovation. The company's commitment to its clients remained unwavering, ensuring continuity and reliability in delivering top-notch software solutions.

Overcoming Cyber Threats and IT Emergencies

In the ever-evolving landscape of cybersecurity, Recursive faced a significant challenge with a targeted cyber attack. However, the company's robust security measures and swift response allowed it to mitigate the impact, protecting both its internal operations and client data. The ability to navigate and overcome such a threat further solidified Recursive's reputation as a trustworthy and secure technology partner.

Diversification into Service Provision and Management

In 2018, Recursive Software Development made a strategic pivot toward Service Provision and Management in the GxP and Pharma sectors. This shift positioned the company as a trusted provider in the industry, and it actively contributed to the development and introduction of standard tools for medical metadata classification. Recursive's involvement in shaping industry standards showcased its commitment to driving innovation and efficiency in the critical field of healthcare.

Pioneering Medical Metadata Classification

The technology developed at Recursive not only streamlines processes but also enhances data accuracy and compliance, addressing crucial needs in the highly regulated GxP environment. Recursive's contribution reflects its dedication to making a lasting impact on the intersection of technology and healthcare.

The Future Looks Promising

As Recursive Software Development enters its second decade, the outlook is both challenging and positive. The company remains committed to innovation, anticipating and adapting to the evolving needs of its clients and the tech industry. With a solid foundation built on a decade of experience, Recursive is poised to continue its upward trajectory, contributing to the advancement of software development and technological solutions.

Recursive Software Development's 10th anniversary is a milestone worth celebrating. From overcoming global challenges to pioneering advancements in the GxP and Pharma sectors, the company has proven its mettle time and again. As we embarks on the next phase of our journey, our commitment to excellence, innovation, and client satisfaction keeps us positioned as a leading force in the ever-evolving world of software development. Here's to another decade of success and groundbreaking achievements!

By Recursive | 11/21/2023

More from our blog:

10 Years!
Recursive Software Development, founded in 2014, celebrates a decade of resilient growth, overcoming a pandemic and cyber threats, pivoting to GxP and Pharma services, and pioneering medical metadata classification, showcasing a positive outlook for the future.

Read More